Full Data Page (Products) List
Notes
GoldenEye Dibrompropamidine Isetionate 0.15% w/w Eye Ointment. (P availability only).
- Waiting data.
- Mid-Optic.
- Tel: 01332 295001.
Details
|
How Supplied Sterile opaque ointment (5.0g) in aluminium tube with screw cap. |
|
Dosing ECP/HCP to advise. Generally "half an inch of ointment inside lower lid on each affected eye". "Apply once or twice per day". If using drops during day and ointment at night pt to apply at night before going to bed. "If condition does not improve after two days, stop using ointment and consult doctor or pharmacist". |
|
Formulation Sterile Ointment containing:, Dibrompropamidine Isetionate 0.15% w/v, Liquid Paraffin, Dispersed Polyethylene, Mineral Oil. |
|
Contact Lens Use No, see Contra-Indications/Cautions |
|
Indications "Minor eye or eyelid infections caused by bacteria, such as conjunctivitis and blepharitis". |
|
Contra-Indications/Cautions Due to the potentially wide range and seriousness of the Contra-indications/Cautions relating to this product the prescriber of this medicine should fully aware of original documentation, SPC, Patient Information Leaflet etc. All pts should be instructed to read the Patient Information Leaflet before using product. Attention is drawn to this products P classification. No contact lens wear during treatment with product. Px not to use product concurrently with other eye drops or ointment. Store below 25C. Discard 4 weeks after first opening. If symptoms do not improve within 2 days - Px to consult pharmacist or doctor. If symptoms become worse - pt to seek medical advice immediately. Pregnancy/lactation - EDDB. Advise pt to read and understand all accompanying product information before first use - EDDB. |
|
Adverse Reactions Due to the potentially wide range and seriousness of the Adverse Reactions relating to this product the prescriber of this medicine should fully aware of original documentation, including SPC and PIL - see notes. All pts should be instructed to read the Patient Information Leaflet before using product. If irritation occurs, persists or increases, pt to discontinue use and consult ECP/HCP - EDDB. If vision changes or irritation occurs, persists or increases, pt to discontinue use and consult ECP/HCP. |
|
Legal Category P |
|
Notes 1. Attention is drawn to this products P classification. 2. Attention is drawn to specific warnings in Contra-Indications/Cautions and Adverse Reactions. 4. Health Care Professionals: http://www.goldeneyecare.co.uk/hcp/hcp-info/ 5. GoldenEye products' website: https://www.goldeneyecare.co.uk/ 5. ON NO ACCOUNT SHOULD THE DATA CONTAINED ON THIS PAGE BE USED AS A BASIS FOR CLINICAL DECISION MAKING/PX ADVICE - THIS SHOULD ONLY BE DONE BY REFERENCE TO THE ORIGINAL PRESCRIBER AND/OR PRODUCT DOCUMENTATION. 6. Because products are regularly improved and change, product data and advice may occasionally change. As a result, EDDB recommends that you and your patient always read the product label and Patient Information Leaflet carefully before using any products. Please do not solely rely on the information provided on this website. Because of this, EDDB is unable to accept liability for any inaccuracies or incorrect information contained on this site. 7. REMINDER: TERMS OF USE. By using this website I agree I am an Eye Care/Health Care Professional and have read, understood and accepted all the terms of use as outlined in the Disclaimer and the Privacy Policy. 8. Pt MUST BE INSTRUCTED TO READ ACCOMPANYING PATIENT INFORMATION LEAFLET BEFORE USE. 9. Attention is drawn to this product's POM/P category and the full relevant legal restrictions therof. 7. Attention is drawn to specific warnings in Contra-Indications/Cautions and Adverse Reactions on this page and the full text of the SPC and PIL, all of which should be read and understood. |
Product information
Not every product may be listed, or have full data. Every effort is being made to fill in the gaps as soon as possible. It will continue to grow in breadth and depth as data arrives and products are released, almost on a daily basis. Endeavours will be made to include information on 'retailers' drops such as Sainsbury's, Superdrug etc, so you can have data available when your patient tells you they are using Tesco Allergy Drops (Sodium Cromoglicate) and asks "can I use it with my contact lenses?". If you would like to propose products for the database, have any ideas, suggestions, would like to provide missing data or see any factual inaccuracies please email adpconsultancy@gmail.com
